FORTREA HOLDINGS INC (FTRE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FTRE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FTRE | Director | 63 | ["Extensive experience in the biopharmaceutical and life sciences industry","Served in executive and board roles for more than three decades","Chairman of the board of Ora Clinical","Member of the board of directors of Launch Therapeutics, Inc.","Previously served on the board of directors of BioCareSD, Inc. and Alcami Corporation","Chief operating officer for PPD from 2007 to 2021","B.S from the U.S. Military Academy at West Point","M.S. in the Management of Technology from the Wharton School and the School of Engineering at the University of Pennsylvania","M.S in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy","M.A. in International Relations from Boston University School of Arts and Sciences","General Management and Business Operations","Finance/Accounting","Mergers and Acquisitions","Risk Management","International Business","Healthcare/Drug Development","Quality and Regulatory","Science and Medicine","Spin Experience"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Sharbaugh was appointed to our Board of Directors on September 22, 2025. Mr. Sharbaugh brings extensive experience in the biopharmaceutical and life sciences industry, having served in executive and board roles during his more than three decades in the pharmaceutical industry. Mr. Sharbaugh currently serves as chairman of the board of Ora Clinical, a specialty ophthalmology contract research organization, as well as a member of the board of directors of Launch Therapeutics, Inc., a late-stage pharmaceutical development company. In addition, Mr. Sharbaugh previously served as a member of the board of directors of BioCareSD, Inc., a drug distribution company, and Alcami Corporation, a contract distribution and manufacturing company. His previous executive experience includes serving as chief operating officer for PPD, a CRO, from 2007 to 2021. Mr. Sharbaugh earned his B.S from the U.S. Military Academy at West Point, a M.S. in the Management of Technology from the Wharton School and the School of Engineering at the University of Pennsylvania, a M.S in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy, and a M.A. in International Relations from Boston University School of Arts and Sciences.